← All trials

NCT07021430

Early Phase 1Interventional

Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 31, 2025
Primary completion
Jul 31, 2027
Completion date
Jul 31, 2027
First posted
Jun 15, 2025
Last posted
Oct 1, 2025
Enrollment
300
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.